Guangzhou Baiyunshan (00874.HK, 600332.SSE) Announces No Change in November 2025 Share Capital

Bulletin Express12-01

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited released its monthly return for the month ended 30 November 2025. The total authorised share capital remained at RMB 1,625,790,949, comprising 219,900,000 H shares and 1,405,890,949 A shares, with a par value of RMB 1 per share.

No changes were recorded in the number of issued H shares and A shares, both holding steady at 219,900,000 and 1,405,890,949 respectively. There were no reported treasury shares, and no movements occurred in share options, warrants, convertibles, or other share issuance arrangements during the month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment